Open AccessEffectiveness of dolutegravir-based antiretroviral therapy in a real-world setting in a Belgian cohort of 4101 HIV patients
Author(s) -
Rakan Nasreddine,
Éric Florence,
Bernard Vandercam,
Michel Moutschen,
JeanChristophe Goffard,
Paul De Munter,
Marc Delforge,
Wouter Marinus,
Stéphane De Wit
Publication year - 2020
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0000000000002533
Subject(s) - discontinuation , dolutegravir , medicine , viral load , cohort , adverse effect , clinical endpoint , population , tolerability , retrospective cohort study , human immunodeficiency virus (hiv) , antiretroviral therapy , clinical trial , immunology , environmental health
To describe the treatment outcomes of patients receiving dolutegravir (DTG) in a 'real-world setting' in Belgium.